Agonist Stereochemistry Determines Beta2-Adrenergic G Protein Coupling

激动剂立体化学测定 Beta2-肾上腺素 G 蛋白偶联

基本信息

  • 批准号:
    7964073
  • 负责人:
  • 金额:
    $ 22.59万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
  • 资助国家:
    美国
  • 起止时间:
  • 项目状态:
    未结题

项目摘要

A fundamental question regarding receptor-G protein interaction is whether different agonists can lead a receptor to different intracellular signaling pathways. Our previous studies have demonstrated that while most beta2-AR agonists activate both Gs and Gi proteins, fenoterol, a full agonist of beta2-AR, selectively activates Gs protein. Fenoterol contains two chiral centers and may exist as four stereoisomers. We have synthesized a series of stereoisomers of fenoterol and its derivatives and characterized their receptor binding and pharmacological properties. We tested the hypothesis that the stereochemistry of an agonist determines selectivity of receptor coupling to different G protein(s). We found that the R,R-isomers of fenoterol and methoxyfenoterol exhibited more potent effects to increase cardiomyocyte contraction than their S,R-isomers. Importantly, while R,R-fenoterol and R,R-methoxyfenoterol preferentially activate Gs signaling, their S,R-isomers were able to activate both Gs and Gi proteins as evidenced by the robust pertussis toxin-sensitivities of their effects on cardiomyocyte contraction and on phosphorylation of extracellular signal-regulated kinase 1/2. The differential G protein selectivities of the fenoterol stereoisomers were further confirmed by photoaffinity labeling studies on Gs, Gi2 and Gi3 proteins. The inefficient Gi signaling with the R,R-isomers is not caused by the inability of the R,R-isomers to trigger the PKA-mediated phosphorylation of the beta2-AR, since the R,R-isomers also markedly increased phosphorylation of the receptor at serine262 by PKA. We conclude that in addition to receptor subtype and phosphorylation status, the stereochemistry of a given agonist plays an important role in determining receptor-G protein selectivity and downstream signaling events.
关于受体- g蛋白相互作用的一个基本问题是不同的激动剂是否可以引导受体进入不同的细胞内信号通路。我们之前的研究表明,虽然大多数β - ar激动剂同时激活Gs和Gi蛋白,但β - ar的完全激动剂非诺特罗选择性地激活Gs蛋白。非诺特罗含有两个手性中心,可以以四个立体异构体的形式存在。我们合成了一系列非诺特罗及其衍生物的立体异构体,并表征了它们的受体结合和药理学性质。我们测试了激动剂的立体化学决定受体偶联到不同G蛋白的选择性的假设。我们发现非诺特罗和甲氧基非诺特罗的R,R-异构体比S,R-异构体更能增强心肌细胞收缩。重要的是,虽然R,R-非诺特罗和R,R-甲氧基非诺特罗优先激活Gs信号,但它们的S,R-异构体能够激活Gs和Gi蛋白,这可以从它们对心肌细胞收缩和细胞外信号调节激酶1/2磷酸化的百日咳毒素敏感性中得到证明。通过对G、Gi2和Gi3蛋白的光亲和标记研究,进一步证实了非诺特罗立体异构体的G蛋白选择性差异。R,R-异构体的Gi信号传导效率低下并非由于R,R-异构体无法触发PKA介导的β 2- ar磷酸化,因为R,R-异构体也显著增加了PKA对受体丝氨酸262的磷酸化。我们得出结论,除了受体亚型和磷酸化状态外,给定激动剂的立体化学在决定受体- g蛋白选择性和下游信号事件中起着重要作用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Rui-Ping Xiao其他文献

Rui-Ping Xiao的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Rui-Ping Xiao', 18)}}的其他基金

CaMKII-dB and CaMKII-dC Oppositely Regulate Cardiomyocyte viability
CaMKII-dB 和 CaMKII-dC 相反地调节心肌细胞活力
  • 批准号:
    7591974
  • 财政年份:
  • 资助金额:
    $ 22.59万
  • 项目类别:
Pi3k Gs Signal Control During B2-adrenergic stimulation
B2 肾上腺素能刺激期间的 Pi3k Gs 信号控制
  • 批准号:
    6674194
  • 财政年份:
  • 资助金额:
    $ 22.59万
  • 项目类别:
Intracellular Acidosis-Activated p38 MAPK & Hypoxia
细胞内酸中毒激活的 p38 MAPK
  • 批准号:
    6969624
  • 财政年份:
  • 资助金额:
    $ 22.59万
  • 项目类别:
Cardiac Excitation-Contraction Coupling by p38 MAPK
p38 MAPK 的心脏兴奋-收缩耦合
  • 批准号:
    6815451
  • 财政年份:
  • 资助金额:
    $ 22.59万
  • 项目类别:
B-Arrestin2 Is Required for BAR Resensitization But Not its Desensitization
B-Arrestin2 是 BAR 重新敏化所必需的,但不是其脱敏所必需的
  • 批准号:
    7732333
  • 财政年份:
  • 资助金额:
    $ 22.59万
  • 项目类别:
B-Arrestin2 Is Required for BAR Resensitization But Not
B-Arrestin2 是 BAR 重新敏化所必需的,但并非如此
  • 批准号:
    7327091
  • 财政年份:
  • 资助金额:
    $ 22.59万
  • 项目类别:
B-Arrestin2 Is Required for BAR Resensitization But Not its Desensitization
B-Arrestin2 是 BAR 重新敏化所必需的,但不是其脱敏所必需的
  • 批准号:
    7592069
  • 财政年份:
  • 资助金额:
    $ 22.59万
  • 项目类别:
Mitochondrial Protein HSG Is a Major Determinant of Oxid
线粒体蛋白 HSG 是氧化的主要决定因素
  • 批准号:
    7327023
  • 财政年份:
  • 资助金额:
    $ 22.59万
  • 项目类别:
Dysregulation of HSG Triggers Proliferative Disorders
HSG 失调会引发增殖性疾病
  • 批准号:
    6968763
  • 财政年份:
  • 资助金额:
    $ 22.59万
  • 项目类别:
Suppression of Beta-arrestin1 Phosphorylation and Function by Beta-arrestin2
Beta-arrestin2 对 Beta-arrestin1 磷酸化和功能的抑制
  • 批准号:
    7964066
  • 财政年份:
  • 资助金额:
    $ 22.59万
  • 项目类别:

相似海外基金

Structural basis for regulation of beta2 adrenergic receptor signaling by the dynamic post-translational modification S-palmitoylation
动态翻译后修饰S-棕榈酰化调节β2肾上腺素受体信号传导的结构基础
  • 批准号:
    10603466
  • 财政年份:
    2023
  • 资助金额:
    $ 22.59万
  • 项目类别:
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    RGPIN-2019-06980
  • 财政年份:
    2022
  • 资助金额:
    $ 22.59万
  • 项目类别:
    Discovery Grants Program - Individual
Glucocorticoid and Adrenergic Receptor Signaling at the Neuroimmune Interface
神经免疫界面的糖皮质激素和肾上腺素能受体信号传导
  • 批准号:
    RGPIN-2019-04706
  • 财政年份:
    2022
  • 资助金额:
    $ 22.59万
  • 项目类别:
    Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574979-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 22.59万
  • 项目类别:
    University Undergraduate Student Research Awards
Angiotensin-(1-7) and beta adrenergic receptor signaling in aging
衰老过程中血管紧张素 (1-7) 和 β 肾上腺素受体信号传导
  • 批准号:
    10629280
  • 财政年份:
    2022
  • 资助金额:
    $ 22.59万
  • 项目类别:
Angiotensin-(1-7) and beta adrenergic receptor signaling in aging
衰老过程中血管紧张素 (1-7) 和 β 肾上腺素受体信号传导
  • 批准号:
    10448574
  • 财政年份:
    2022
  • 资助金额:
    $ 22.59万
  • 项目类别:
Novel regulation of beta-adrenergic receptor function by phosphoinositide 3-kinase
磷酸肌醇 3-激酶对 β-肾上腺素能受体功能的新调节
  • 批准号:
    10591688
  • 财政年份:
    2022
  • 资助金额:
    $ 22.59万
  • 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574984-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 22.59万
  • 项目类别:
    University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574985-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 22.59万
  • 项目类别:
    University Undergraduate Student Research Awards
The molecular mechanism of the crosstalk between the beta-2 adrenergic receptor and chemokine receptors in lymphocytes
淋巴细胞β2肾上腺素受体与趋化因子受体串扰的分子机制
  • 批准号:
    22K07118
  • 财政年份:
    2022
  • 资助金额:
    $ 22.59万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了